NCT05677607 Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease
| NCT ID | NCT05677607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese PLA General Hospital |
| Condition | ICAS - Intracranial Atherosclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2023-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study aims at verifying the mutual effects between intracranial large artery atherosclerosis and cerebral small vessel disease on disease progression and prognosis by magnetic resonance imaging, and providing biomarkers for the early prevention and treatment of cerebrovascular disease.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * At least one intracranial artery ≥ 50% atherosclerotic stenosis * Modified Rankin Scale \< 2 * Mini-mental State Examination \> 24 Exclusion Criteria: * Concurrent ipsilateral extracranial artery ≥ 50% stenosis * Pregnant women * Contraindications to magnetic resonance examination (patients with pacemakers, nerve stimulators, artificial metal heart valves and other metal foreign bodies)
Contact & Investigator
Jinhao Lyu
PRINCIPAL INVESTIGATOR
Chinese PLA General Hospital
Frequently Asked Questions
Who can join the NCT05677607 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying ICAS - Intracranial Atherosclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05677607 currently recruiting?
Yes, NCT05677607 is actively recruiting participants. Contact the research team at 330322990@qq.com for enrollment information.
Where is the NCT05677607 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05677607 clinical trial?
NCT05677607 is sponsored by Chinese PLA General Hospital. The principal investigator is Jinhao Lyu at Chinese PLA General Hospital. The trial plans to enroll 300 participants.